CAS 1361198-79-9

NEO 212

CAS: 1361198-79-9

NEO 212 is a potent inhibitor of kinases, which are enzymes that play a critical role in cell signaling pathways. It induces apoptosis, or programmed cell death, in tumor cells and has shown promising results as an anticancer drug. NEO 212 is an analog of nintedanib, a kinase inhibitor that has been approved for the treatment of certain types of cancer. In preclinical studies, NEO 212 has demonstrated strong activity against various types of cancer cells, including those resistant to other inhibitors. It has also shown efficacy in Chinese hamster ovary cells and human urine-derived cells. This innovative drug holds great promise as a novel therapy for cancer patients.

Fórmula: C₁₇H₂₀N₆O₄

Pureza: Min. 95%

Peso molecular: 372.4 g/mol

Ref: 3D-LEC19879